Journal
TRENDS IN CANCER
Volume 3, Issue 5, Pages 372-386Publisher
CELL PRESS
DOI: 10.1016/j.trecan.2017.04.004
Keywords
-
Categories
Funding
- Francis Crick Institute
- Cancer Research UK [FC001152]
- UK Medical Research Council [FC001152]
- Wellcome Trust [FC001152]
- The Francis Crick Institute [10152] Funding Source: researchfish
Ask authors/readers for more resources
Epigenetic mechanisms have emerged as key players in cancer development which affect cellular states at multiple stages of the disease. During carcinogenesis, alterations in chromatin and DNA methylation resulting from genetic lesions unleash cellular plasticity and favor oncogenic cellular reprogramming. At later stages, during cancer growth and progression, additional epigenetic changes triggered by interaction with the microenvironment modulate cancer cell phenotypes and properties, and shape tumor architecture. We review here recent advances highlighting the interplay between epigenetics, genetics, and cell-to-cell signaling in cancer, with particular emphasis on mechanisms relevant for cancer stem cell formation (CSC) and function.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available